Characterization of a novel metastatic prostate cancer cell line of LNCaP origin
The Prostate2015Vol. 76(2), pp. 215–225
Citations Over Time
Mark Castanares, Ben T. Copeland, Wasim H. Chowdhury, Minzhi M. Liu, Ronald Rodríguez, Martin G. Pomper, Shawn E. Lupold, Catherine A. Foss
Abstract
The JHU-LNCaP-SM cell line is a new isolate of LNCaP, which facilitates practical, preclinical studies of spontaneous metastasis of prostate cancer through lymphatic tissues.
Related Papers
- Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.(2001)
- → Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system(1999)420 cited
- → p-Carborane-based androgen antagonists active in LNCaP cells with a mutated androgen receptor(2011)27 cited
- → Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells(2011)20 cited
- Cell growth promoting of the androgen receptor mutation(2006)